Pune biotech firm announces cheaper drug for colorectal cancer

[ad_1]

Pune-based biotech firm Enzene Biosciences has announced the launch of Bevacizumab, a biosimilar alternative to the more expensive Avastin that is used for treatment of metastatic colorectal cancer.

Bevacizumab is the sixth biosimilar from Enzene Biosciences’s pipeline. “Aimed at penetrating the Indian market for Bevacizumab that is valued at Rs 260 crore, Enzene’s version is the first to be manufactured using the firm’s patented continuous manufacturing process at its Pune facility,” said Dr. Himanshu Gadgil, CEO of Enzene Biosciences Ltd.

“We are confident that the significant price reductions passed on by our partners will greatly benefit thousands of metastatic colorectal cancer patients, supporting our mission to make cancer treatment more accessible and affordable,” he added.



[ad_2]

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Daily Horoscope for Friday, June 30, 2023, for all zodiac signs by astrologer Vinayak Vishwas Karandikar

Next Post

Check out the Tithi, Shubh Muhurat, Moon Sign, and Name Letter for Newborn on June 30, 2023

Related Posts
Following allegations of irregularities in the excise policy, the Delhi Deputy Chief Minister, Manish Sisodia, has been sent to a five-day CBI remand custody.

Following allegations of irregularities in the excise policy, the Delhi Deputy Chief Minister, Manish Sisodia, has been sent to a five-day CBI remand custody.

The political landscape of Delhi witnessed a major upheaval when the Deputy Chief Minister of the state, Manish Sisodia, was sent to a five-day remand custody by the Central Bureau of Investigation (CBI) in connection with the alleged irregularities in the excise policy for the year 2021-22. The development has further intensified the already escalating political battle between the ruling Aam Aadmi Party (AAP) and the opposition Bharatiya Janata Party (BJP).
Read More